ARBUTUS BIOPHARMA
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). They believe that Arbutus' comprehensive HBV pipeline of drugs and drug candidates optimally positions us to transform the HBV treatment landscape and to capitalize on the HBV global market opportunity. They are developing a portfolio ... of drug candidates with multiple mechanisms of action that They believe will result in a combination therapy to cure HBV. Specifically, They seek to effect a cure by targeting the three pillars necessary to develop a curative regimen for HBV. This includes suppressing HBV replication within liver cells, stimulating and reactivating the body’s immune system so that it can mount an effective defense against the virus and eliminating the reservoir of viral genomic material known as covalently closed circular DNA, or cccDNA, that is the source of HBV persistence.
ARBUTUS BIOPHARMA
Industry:
Biopharma Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
1992-01-01
Address:
Burnaby, British Columbia, Canada
Country:
Canada
Website Url:
http://www.arbutusbio.com
Total Employee:
51+
Status:
Active
Contact:
(604) 419-3200
Total Funding:
141.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
BirchBioMed
BirchBioMed is a clinical-stage biomedical company.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cassava Sciences
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
Chromis Therapeutics
Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company
Frontida Biopharm
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Kura Oncology
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Touchlight Genetics
Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company.
CareDx
CareDx is a novel molecular diagnostics company.
Yisheng Biopharma
Yisheng Biopharma is a global, fully integrated bio-pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-01-13 | OnCore Biopharma | OnCore Biopharma acquired by Arbutus Biopharma | N/A |
| 2008-03-28 | Protiva Biotherapeutics | Protiva Biotherapeutics acquired by Arbutus Biopharma | 22.8 M USD |
Investors List
Roivant Sciences
Roivant Sciences investment in Post-IPO Equity - Arbutus Biopharma
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Arbutus Biopharma
National Institutes of Health
National Institutes of Health investment in Grant - Arbutus Biopharma
Official Site Inspections
http://www.arbutusbio.com Semrush global rank: 1.99 M Semrush visits lastest month: 10.7 K
- Host name: 226.108.198.104.bc.googleusercontent.com
- IP address: 104.198.108.226
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
